Premium Nahrungsergänzungsmittel | artgerecht

Donepezil: Uses, Dosage & Side Effects

Donepezil is a prescription medication used to treat Alzheimer's disease. It helps improve cognitive function and slow the progression of symptoms.

Regular tips about health Regular tips about health

Things worth knowing about "Donepezil"

Donepezil is a prescription medication used to treat Alzheimer's disease. It helps improve cognitive function and slow the progression of symptoms.

What is Donepezil?

Donepezil is a prescription medication used in the treatment of Alzheimer's disease. It belongs to the pharmacological class of acetylcholinesterase inhibitors (also called cholinesterase inhibitors) and has been one of the most widely prescribed drugs for Alzheimer's disease since its approval in the 1990s. Donepezil is indicated for mild, moderate, and severe stages of Alzheimer's disease.

Mechanism of Action

In patients with Alzheimer's disease, the neurotransmitter acetylcholine is present in reduced amounts in the brain. Acetylcholine plays a critical role in transmitting nerve signals involved in memory, learning, and attention.

Donepezil works by inhibiting the enzyme acetylcholinesterase, which is responsible for breaking down acetylcholine. By blocking this enzyme, donepezil prevents the rapid degradation of acetylcholine, thereby increasing its concentration in the brain. This enhances nerve cell communication and can alleviate cognitive symptoms associated with Alzheimer's disease.

Indications and Uses

Donepezil is approved for:

Mild Alzheimer's disease: Improvement of memory and daily functioning in early disease stages.
Moderate Alzheimer's disease: Slowing cognitive decline and supporting activities of daily living.
Severe Alzheimer's disease: Alleviating behavioral disturbances and stabilizing remaining abilities.

In some countries, donepezil is also being studied for other forms of dementia such as Lewy body dementia and vascular dementia, although it is not officially approved for these indications.

Dosage

Donepezil is typically taken orally once daily, preferably in the evening before bedtime. The standard starting dose is 5 mg per day. After four to six weeks, the dose may be increased to 10 mg per day if well tolerated. For severe Alzheimer's disease, a 23 mg extended-release tablet is approved in some countries.

Donepezil can be taken with or without food. It is available as a film-coated tablet, an orally disintegrating tablet, and as an oral solution.

Side Effects

Like all medications, donepezil can cause side effects. The most commonly reported side effects affect the gastrointestinal tract and nervous system:

Common (>1/10): Nausea, diarrhea, vomiting, headache, insomnia, dizziness, muscle cramps
Uncommon (1/100 to 1/10): Bradycardia (slowed heart rate), fatigue, loss of appetite, syncope (fainting)
Rare (<1/100): Gastrointestinal bleeding, liver problems, seizures

Many side effects occur mainly at the start of treatment and tend to diminish after a few weeks. A gradual dose increase can help minimize unwanted effects.

Contraindications and Interactions

Donepezil should not be used in patients with known hypersensitivity to the active substance or related compounds. Special caution is required in patients with:

Cardiac arrhythmias (especially bradycardia or AV block)
Peptic ulcers or concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs)
Asthma or chronic obstructive pulmonary disease (COPD)
Epilepsy

Interactions may occur with muscle relaxants, anticholinergic drugs, and certain cardiac medications such as beta-blockers. Patients should always consult their physician before starting donepezil therapy.

Treatment Context and Efficacy

Donepezil does not cure Alzheimer's disease and cannot halt the underlying neurodegenerative process. However, it can relieve cognitive symptoms such as memory loss, disorientation, and language difficulties, and may help patients maintain independence for longer. Clinical trials have demonstrated that patients receiving donepezil show measurably better cognitive performance compared to those receiving placebo.

Therapy is regularly reviewed by a physician to assess the balance of benefits and risks. If a patient does not respond adequately or experiences significant side effects, switching to alternative agents such as rivastigmine or galantamine may be considered.

References

Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews. 2018;(6):CD001190. doi:10.1002/14651858.CD001190.pub3
National Institute for Health and Care Excellence (NICE). Dementia: assessment, management and support for people living with dementia and their carers. NICE Guideline NG97. 2018. Available at: https://www.nice.org.uk/guidance/ng97
European Medicines Agency (EMA). Aricept (donepezil) - Product Information. Available at: https://www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.